275 related articles for article (PubMed ID: 22673234)
1. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells.
Shatz M; Menendez D; Resnick MA
Cancer Res; 2012 Aug; 72(16):3948-57. PubMed ID: 22673234
[TBL] [Abstract][Full Text] [Related]
2. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks.
Menendez D; Shatz M; Azzam K; Garantziotis S; Fessler MB; Resnick MA
PLoS Genet; 2011 Mar; 7(3):e1001360. PubMed ID: 21483755
[TBL] [Abstract][Full Text] [Related]
3. Interactions between the tumor suppressor p53 and immune responses.
Menendez D; Shatz M; Resnick MA
Curr Opin Oncol; 2013 Jan; 25(1):85-92. PubMed ID: 23150340
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Toll-Like Receptor Signaling on the Activation of Immune Responses in the Upper Respiratory Tract.
Xu M; Li N; Fan X; Zhou Y; Bi S; Shen A; Wang B
Microbiol Spectr; 2022 Feb; 10(1):e0114421. PubMed ID: 35196817
[TBL] [Abstract][Full Text] [Related]
5. p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways.
Shatz M; Shats I; Menendez D; Resnick MA
Oncotarget; 2015 Jul; 6(19):16963-80. PubMed ID: 26220208
[TBL] [Abstract][Full Text] [Related]
6. Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells.
Menendez D; Lowe JM; Snipe J; Resnick MA
Oncotarget; 2016 Sep; 7(38):61630-61642. PubMed ID: 27533082
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Rodríguez A; Ortiz-Ferrón G; Redondo JM; López-Rivas A
J Biol Chem; 2004 Feb; 279(6):4093-101. PubMed ID: 14623878
[TBL] [Abstract][Full Text] [Related]
8. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
9. p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus.
Menendez D; Snipe J; Marzec J; Innes CL; Polack FP; Caballero MT; Schurman SH; Kleeberger SR; Resnick MA
J Clin Invest; 2019 Nov; 129(11):4875-4884. PubMed ID: 31430261
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
Cui Y; Guo G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
[TBL] [Abstract][Full Text] [Related]
11. P53: A Guardian of Immunity Becomes Its Saboteur through Mutation.
Agupitan AD; Neeson P; Williams S; Howitt J; Haupt S; Haupt Y
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414156
[TBL] [Abstract][Full Text] [Related]
12. The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.
Ciribilli Y; Andreotti V; Menendez D; Langen JS; Schoenfelder G; Resnick MA; Inga A
PLoS One; 2010 Apr; 5(4):e10236. PubMed ID: 20422012
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS
Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466
[TBL] [Abstract][Full Text] [Related]
14. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
15. Expression of androgen receptor is negatively regulated by p53.
Alimirah F; Panchanathan R; Chen J; Zhang X; Ho SM; Choubey D
Neoplasia; 2007 Dec; 9(12):1152-9. PubMed ID: 18084622
[TBL] [Abstract][Full Text] [Related]
16. p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines.
Taura M; Eguma A; Suico MA; Shuto T; Koga T; Komatsu K; Komune T; Sato T; Saya H; Li JD; Kai H
Mol Cell Biol; 2008 Nov; 28(21):6557-67. PubMed ID: 18779317
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.
Tsou SH; Hou MH; Hsu LC; Chen TM; Chen YH
Int J Mol Med; 2016 Jan; 37(1):233-42. PubMed ID: 26572087
[TBL] [Abstract][Full Text] [Related]
18. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
19. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
Sheikh MS; Huang Y; Fernandez-Salas EA; El-Deiry WS; Friess H; Amundson S; Yin J; Meltzer SJ; Holbrook NJ; Fornace AJ
Oncogene; 1999 Jul; 18(28):4153-9. PubMed ID: 10435597
[TBL] [Abstract][Full Text] [Related]
20. Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells.
Tsuda Y; Tanikawa C; Miyamoto T; Hirata M; Yodsurang V; Zhang YZ; Imoto S; Yamaguchi R; Miyano S; Takayanagi H; Kawano H; Nakagawa H; Tanaka S; Matsuda K
Sci Rep; 2017 Sep; 7(1):10739. PubMed ID: 28878391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
